Holly L. Peay

4.2k total citations
122 papers, 1.8k citations indexed

About

Holly L. Peay is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Genetics. According to data from OpenAlex, Holly L. Peay has authored 122 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 30 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Holly L. Peay's work include Muscle Physiology and Disorders (25 papers), Ethics in Clinical Research (21 papers) and Neurogenetic and Muscular Disorders Research (16 papers). Holly L. Peay is often cited by papers focused on Muscle Physiology and Disorders (25 papers), Ethics in Clinical Research (21 papers) and Neurogenetic and Muscular Disorders Research (16 papers). Holly L. Peay collaborates with scholars based in United States, Netherlands and Canada. Holly L. Peay's co-authors include Ilene L. Hollin, Barbara B. Biesecker, John F. P. Bridges, Ryan Fischer, Ann Martin, Gail E. Henderson, Aad Tibben, Benjamin M. Craig, Joanna Coast and Ian D. Coulter and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Holly L. Peay

111 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly L. Peay United States 27 423 403 349 291 276 122 1.8k
Mary Ann Thompson United States 29 715 1.7× 250 0.6× 345 1.0× 179 0.6× 72 0.3× 69 2.6k
Thomas Frisell Sweden 38 251 0.6× 194 0.5× 510 1.5× 165 0.6× 104 0.4× 133 4.4k
Vence L. Bonham United States 28 396 0.9× 956 2.4× 630 1.8× 452 1.6× 143 0.5× 93 2.6k
Emily Harris United States 23 252 0.6× 476 1.2× 177 0.5× 134 0.5× 57 0.2× 163 2.2k
Alan L. Shields United States 23 224 0.5× 64 0.2× 249 0.7× 355 1.2× 176 0.6× 72 2.5k
Marie Y. Mann United States 21 328 0.8× 506 1.3× 140 0.4× 376 1.3× 235 0.9× 44 2.1k
Ian Porter United Kingdom 23 272 0.6× 307 0.8× 233 0.7× 258 0.9× 168 0.6× 76 1.7k
Kimberly A. Dukes United States 23 244 0.6× 324 0.8× 392 1.1× 209 0.7× 103 0.4× 41 3.2k
Arlene M. Davis United States 20 148 0.3× 306 0.8× 902 2.6× 452 1.6× 165 0.6× 50 1.5k
Ramón Vélez United States 26 594 1.4× 149 0.4× 208 0.6× 417 1.4× 155 0.6× 51 3.0k

Countries citing papers authored by Holly L. Peay

Since Specialization
Citations

This map shows the geographic impact of Holly L. Peay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly L. Peay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly L. Peay more than expected).

Fields of papers citing papers by Holly L. Peay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly L. Peay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly L. Peay. The network helps show where Holly L. Peay may publish in the future.

Co-authorship network of co-authors of Holly L. Peay

This figure shows the co-authorship network connecting the top 25 collaborators of Holly L. Peay. A scholar is included among the top collaborators of Holly L. Peay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly L. Peay. Holly L. Peay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moultrie, Rebecca, Gail E. Henderson, D. M. Jackman, et al.. (2025). Development and Evaluation of Decision Partner: A Decision Aid for HIV Remission Clinical Trial Participation. AIDS and Behavior. 29(10). 3125–3140. 1 indexed citations
2.
3.
Tzeng, Janice, et al.. (2024). Parent perspectives following newborn screening resulting in diagnoses of fragile X syndrome or fragile X premutation. Research in Developmental Disabilities. 148. 104719–104719.
4.
5.
Kucera, Katerina S., Verónica Robles, Heidi Cope, et al.. (2023). P497: Two years of newborn screening for Duchenne Muscular Dystrophy in North Carolina: Results from Early Check*. SHILAP Revista de lepidopterología. 1(1). 100544–100544.
6.
Fischer, Ryan, et al.. (2023). A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 10(4). 593–613. 3 indexed citations
7.
Kucera, Katerina S., Heidi Cope, Anne Wheeler, et al.. (2023). Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina. Genetics in Medicine. 26(1). 101009–101009. 9 indexed citations
8.
Rennie, Stuart, Gail E. Henderson, Nittaya Phanuphak, et al.. (2023). The Essential Need for Trust When Transmission Risk Cannot Be Eliminated in HIV‐Remission Trials. PubMed. 45(4). 2–15. 4 indexed citations
9.
Richter, Lucas, Theodore Morley, Gillian W. Hooker, et al.. (2022). Leveraging electronic health records to inform genetic counseling practice surrounding psychiatric disorders. Journal of Genetic Counseling. 31(4). 1008–1015. 2 indexed citations
10.
Dijkstra, Maartje, Holly L. Peay, Casper Rokx, et al.. (2022). Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection. Journal of Virus Eradication. 8(2). 100072–100072. 10 indexed citations
11.
Henderson, Gail E., Stuart Rennie, Amy Corneli, & Holly L. Peay. (2020). Cohorts as collections of bodies and communities of persons: insights from the SEARCH010/RV254 research cohort. International Health. 12(6). 584–590. 6 indexed citations
12.
Peay, Holly L., Gail E. Henderson, Thidarat Jupimai, et al.. (2020). Recommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: report from a participatory workshop. International Health. 12(6). 567–574. 6 indexed citations
13.
Paquin, Ryan S., Megan A. Lewis, Rebecca Moultrie, et al.. (2020). Outreach to new mothers through direct mail and email: recruitment in the Early Check research study. Clinical and Translational Science. 14(3). 880–889. 8 indexed citations
14.
Raspa, Melissa, Molly Lynch, Linda Squiers, et al.. (2020). Information and Emotional Support Needs of Families Whose Infant Was Diagnosed With SCID Through Newborn Screening. Frontiers in Immunology. 11. 885–885. 15 indexed citations
15.
Biesecker, Barbara B., et al.. (2019). Uncertainty, hope, and coping efficacy among mothers of children with Duchenne/Becker muscular dystrophy. Clinical Genetics. 95(6). 677–683. 13 indexed citations
16.
17.
Khodyakov, Dmitry, Sean Grant, Kathi Kinnett, et al.. (2019). The RAND/PPMD Patient-Centeredness Method: a novel online approach to engaging patients and their representatives in guideline development. Publisher. 6 indexed citations
18.
Peay, Holly L., et al.. (2017). Psychosocial Needs and Facilitators of Mothers Caring for Children with Duchenne/Becker Muscular Dystrophy. Journal of Genetic Counseling. 27(1). 197–203. 7 indexed citations
19.
Khodyakov, Dmitry, Kathi Kinnett, Sean Grant, et al.. (2017). Engaging Patients and Caregivers Managing Rare Diseases to Improve the Methods of Clinical Guideline Development: A Research Protocol. JMIR Research Protocols. 6(4). e57–e57. 15 indexed citations
20.
Hollin, Ilene L., et al.. (2016). Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process. Value in Health. 19(6). 751–757. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Ann Thompson Breakdown of academic impact, for papers by Thomas Frisell Breakdown of academic impact, for papers by Vence L. Bonham Breakdown of academic impact, for papers by Emily Harris Breakdown of academic impact, for papers by Alan L. Shields Breakdown of academic impact, for papers by Marie Y. Mann Breakdown of academic impact, for papers by Ian Porter Breakdown of academic impact, for papers by Kimberly A. Dukes Breakdown of academic impact, for papers by Arlene M. Davis Breakdown of academic impact, for papers by Ramón Vélez
Rankless by CCL
2026